GW Pharma So InMed has a more advance technology for producing canabinoids than GW however, GW is further ahead in their cannabis derived drug pipeline with revenues from Epidiolex. Looks like further catalysts that company are coming soon and they report on Thursday. https://www.google.ca/amp/s/www.fool.com/amp/investing/2020/07/25/3-biotech-stocks-with-big-incoming-catalysts.aspx